0001795251
false
Q2
--12-31
2026-06-30
0001795251
2026-01-01
2026-06-30
0001795251
us-gaap:SubsequentEventMember
2026-08-31
2026-08-31
0001795251
2026-08-13
2026-08-13
0001795251
us-gaap:SubsequentEventMember
2026-08-13
2026-08-13
0001795251
us-gaap:SubsequentEventMember
srt:MaximumMember
2026-08-07
2026-08-07
0001795251
us-gaap:SubsequentEventMember
srt:MinimumMember
2026-08-07
2026-08-07
0001795251
us-gaap:SubsequentEventMember
2026-08-07
2026-08-07
0001795251
us-gaap:SubsequentEventMember
us-gaap:RestrictedStockUnitsRSUMember
2026-08-07
2026-08-07
0001795251
us-gaap:SubsequentEventMember
2026-08-07
0001795251
2026-07-31
2026-07-31
0001795251
us-gaap:SubsequentEventMember
2026-07-31
2026-07-31
0001795251
us-gaap:RestrictedStockUnitsRSUMember
2025-01-01
2025-06-30
0001795251
us-gaap:RestrictedStockUnitsRSUMember
2026-01-01
2026-06-30
0001795251
2025-01-01
2025-06-30
0001795251
2025-06-30
0001795251
2026-06-30
0001795251
2025-04-01
2025-06-30
0001795251
nnox:AIAndSoftwareSolutionsMember
2025-04-01
2025-06-30
0001795251
nnox:RadiologyServicesMember
2025-04-01
2025-06-30
0001795251
nnox:NanoxARCMember
2025-04-01
2025-06-30
0001795251
nnox:NanoxHealthITIncMember
2026-04-01
2026-06-30
0001795251
2026-04-01
2026-06-30
0001795251
nnox:AIAndSoftwareSolutionsMember
2026-04-01
2026-06-30
0001795251
nnox:RadiologyServicesMember
2026-04-01
2026-06-30
0001795251
nnox:NanoxARCMember
2026-04-01
2026-06-30
0001795251
nnox:RadiologyServicesMember
2025-01-01
2025-06-30
0001795251
nnox:NanoxARCMember
2025-01-01
2025-06-30
0001795251
nnox:AIAndSoftwareSolutionsMember
2025-06-30
0001795251
nnox:RadiologyServicesMember
2025-06-30
0001795251
nnox:NanoxARCMember
2025-06-30
0001795251
nnox:AIAndSoftwareSolutionsMember
2025-01-01
2025-06-30
0001795251
nnox:NanoxHealthITIncMember
2026-01-01
2026-06-30
0001795251
nnox:NanoxARCMember
2026-01-01
2026-06-30
0001795251
nnox:AIAndSoftwareSolutionsMember
2026-06-30
0001795251
nnox:RadiologyServicesMember
2026-06-30
0001795251
nnox:NanoxARCMember
2026-06-30
0001795251
nnox:AIAndSoftwareSolutionsMember
2026-01-01
2026-06-30
0001795251
nnox:RadiologyServicesMember
2026-01-01
2026-06-30
0001795251
nnox:FirstAnniversaryMember
2026-06-23
2026-06-23
0001795251
us-gaap:RestrictedStockUnitsRSUMember
2026-06-23
2026-06-23
0001795251
nnox:FirstAnniversaryMember
2026-01-01
2026-06-30
0001795251
us-gaap:RestrictedStockUnitsRSUMember
2026-02-05
2026-02-05
0001795251
nnox:SecondAnniversaryMember
2026-02-05
2026-02-05
0001795251
nnox:FirstAnniversaryMember
2026-02-05
2026-02-05
0001795251
2026-02-05
2026-02-05
0001795251
2025-12-31
0001795251
us-gaap:CommonStockMember
2026-05-01
2026-05-01
0001795251
nnox:MDWEBLLCMember
2025-05-01
2025-05-31
0001795251
us-gaap:CommonStockMember
2025-12-31
0001795251
us-gaap:CommonStockMember
2026-06-30
0001795251
nnox:NanoxAIMember
2026-01-01
2026-06-30
0001795251
nnox:IIAGrantsMember
2026-01-01
2026-06-30
0001795251
2023-05-01
2023-05-01
0001795251
2023-05-01
0001795251
nnox:ImageBigDataMember
2026-01-01
2026-06-30
0001795251
us-gaap:TechnologyBasedIntangibleAssetsMember
2026-01-01
2026-06-30
0001795251
nnox:AISolutionsReportingUnitMember
2026-01-01
2026-06-30
0001795251
us-gaap:FairValueInputsLevel3Member
2025-12-31
0001795251
us-gaap:FairValueInputsLevel3Member
2026-06-30
0001795251
us-gaap:FairValueInputsLevel3Member
2026-01-01
2026-06-30
0001795251
us-gaap:FairValueInputsLevel3Member
2025-01-01
2025-12-31
0001795251
us-gaap:CashAndCashEquivalentsMember
2025-12-31
0001795251
us-gaap:FairValueMeasurementsRecurringMember
2025-12-31
0001795251
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2025-12-31
0001795251
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2025-12-31
0001795251
us-gaap:FairValueMeasurementsRecurringMember
2026-06-30
0001795251
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2026-06-30
0001795251
us-gaap:CommonStockMember
2026-06-30
0001795251
2024-12-31
0001795251
us-gaap:RetainedEarningsMember
2025-06-30
0001795251
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-06-30
0001795251
us-gaap:AdditionalPaidInCapitalMember
2025-06-30
0001795251
us-gaap:CommonStockMember
2025-06-30
0001795251
us-gaap:RetainedEarningsMember
2025-04-01
2025-06-30
0001795251
us-gaap:AdditionalPaidInCapitalMember
2025-04-01
2025-06-30
0001795251
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-04-01
2025-06-30
0001795251
us-gaap:CommonStockMember
2025-04-01
2025-06-30
0001795251
2025-03-31
0001795251
us-gaap:RetainedEarningsMember
2025-03-31
0001795251
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-03-31
0001795251
us-gaap:AdditionalPaidInCapitalMember
2025-03-31
0001795251
us-gaap:CommonStockMember
2025-03-31
0001795251
us-gaap:RetainedEarningsMember
2026-06-30
0001795251
us-gaap:AdditionalPaidInCapitalMember
2026-06-30
0001795251
us-gaap:RetainedEarningsMember
2026-04-01
2026-06-30
0001795251
us-gaap:AdditionalPaidInCapitalMember
2026-04-01
2026-06-30
0001795251
us-gaap:CommonStockMember
2026-04-01
2026-06-30
0001795251
2026-03-31
0001795251
us-gaap:RetainedEarningsMember
2026-03-31
0001795251
us-gaap:AdditionalPaidInCapitalMember
2026-03-31
0001795251
us-gaap:CommonStockMember
2026-03-31
0001795251
us-gaap:RetainedEarningsMember
2025-01-01
2025-06-30
0001795251
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-01-01
2025-06-30
0001795251
us-gaap:AdditionalPaidInCapitalMember
2025-01-01
2025-06-30
0001795251
us-gaap:CommonStockMember
2025-01-01
2025-06-30
0001795251
us-gaap:RetainedEarningsMember
2024-12-31
0001795251
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-12-31
0001795251
us-gaap:AdditionalPaidInCapitalMember
2024-12-31
0001795251
us-gaap:CommonStockMember
2024-12-31
0001795251
us-gaap:RetainedEarningsMember
2026-01-01
2026-06-30
0001795251
us-gaap:AdditionalPaidInCapitalMember
2026-01-01
2026-06-30
0001795251
us-gaap:CommonStockMember
2026-01-01
2026-06-30
0001795251
us-gaap:RetainedEarningsMember
2025-12-31
0001795251
us-gaap:AdditionalPaidInCapitalMember
2025-12-31
0001795251
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-12-31
0001795251
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2026-06-30
0001795251
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2026-01-01
2026-06-30
0001795251
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2026-03-31
0001795251
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2026-04-01
2026-06-30
0001795251
us-gaap:FairValueInputsLevel3Member
2024-12-31
0001795251
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2026-06-30
0001795251
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2026-06-30
0001795251
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2025-12-31
iso4217:USD
xbrli:pure
xbrli:shares
iso4217:USD
xbrli:shares
iso4217:ILS
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of September 2026
Commission File Number: 001-39461
NANO-X IMAGING LTD
Ofer Tech Park
94 Shlomo Shmeltzer Road
Petach Tikva
Israel 4970602
(Address of principal executive office)
Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form
40-F ☐
CONTENTS
Quarterly Results of Operations
On September 9, 2026, NANO-X IMAGING LTD (the “Company”, “Nanox”, “we” or “us”) announced its financial results for the second quarter ended June 30, 2026. A copy of our press release announcing those results is furnished as Exhibit 99.1 to this Report of Foreign Private Issuer on Form 6-K (this “Form 6-K”) and is incorporated herein by reference.
Attached hereto as Exhibit 99.2 are the unaudited, condensed consolidated financial statements of Nanox as of, and for the three and six months ended, June 30, 2026 (including the notes thereto) (the “Q2 2026 Financial Statements”).
Attached hereto as Exhibit 99.3 are Nanox’s Operating and Financial Review and Prospects as of, and for the six months ended, June 30, 2026.
Attached hereto as Exhibit 101 are the Q2 2026 Financial Statements, formatted in IXBRL (eXtensible Business Reporting Language), consisting of the sub-exhibits listed in the exhibit table below.
Incorporation by Reference
The Q2 2026 Financial Statements attached to this Form 6-K as Exhibit 99.2 and the Operating and Financial Review and Prospects as of, and for the six months ended, June 30, 2026 attached to this Form 6-K as Exhibit 99.3, are incorporated by reference into the Company’s Registration Statements on Form F-3 (File No. 333-294302), and Form S-8 (File No. 333-248322).
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| NANO-X IMAGING LTD | | |
| (Registrant) | | |
| | | |
| Date: September 9, 2026 | By: | /s/ Erez Meltzer |
| Name: | Erez Meltzer |
| Title: | Chief Executive Officer and Acting Chairman of the Board |